The UK is enjoying real success with its COVID-19 vaccine coverage. Around 85% of adults (44.8 million people) have received one vaccine dose and 63% (33 million people) both doses, with around 160,000 doses a day still being administered.
Vaccination with two doses helps prevent infection, and in those that do still get infected, lessens the impact of the virus by reducing disease severity, transmission of infection and death.
Even so, plans to give people a third shot have been unveiled by the UK’s Joint Committee on Vaccination and Immunisation (JCVI). The two main arguments to support giving a third dose are that the effectiveness of the first two jabs falls over time, and that there’s a need to take new vaccines to deal with viral variants, such as the delta variant. But what does the evidence say?
theconversation.com/covid-1...
Research Square. The Pre-print of the Research Paper in the article (PDF file)